13F Holdings
中文EN

PSNL Personalis, Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 1527753 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY16.9%
TTM net income YoY-61.5%
TTM EPS YoY-39.8%
Revenue 3-yr CAGR4.6%
Net income 3-yr CAGR—

Margins

Gross margin16.7%
Operating margin-156.7%
Net margin-147.7%
FCF margin-133.3%
EBITDA margin-144.6%

Returns

ROE-62.1%
ROA-44.7%
ROIC (approx.)-84.8%
Asset turnover0.30x

Leverage & solvency

Liabilities / assets27.1%
Debt / equity0.00x
Current ratio4.53x
Interest coverage-683.98x

Cash quality & payout

Operating cash flow / net income0.82x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue12.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$69.65M$84.61M$73.48M$65.05M$85.49M
Cost of revenue$53.87M$57.79M$55.27M$51.70M$53.84M
Gross profit$15.78M$26.82M$18.21M$13.35M$31.66M
R&D expense$50.26M$48.91M$64.78M$64.91M$49.31M
SG&A expense$53.57M$46.19M$49.73M$63.97M$47.70M
Operating income-$88.06M-$68.27M-$109.94M-$115.53M-$65.35M
Interest expense$205,000$24,000$110,000$201,000$184,000
Pretax income-$81.25M-$81.27M-$108.21M-$113.28M-$65.21M
Income tax$21,000$18,000$83,000$40,000$14,000
Net income-$81.27M-$81.28M-$108.30M-$113.31M-$65.23M
EBITDA-$78.01M-$57.33M-$98.64M-$107.10M-$59.34M
EPS (basic)-0.91-1.37-2.25-2.48-1.49
EPS (diluted)-0.91-1.37-2.25-2.48-1.49
Weighted avg. shares (diluted)89.24M59.25M48.18M45.70M43.89M
Balance sheet
Cash & equivalents$124.25M$91.42M$56.98M$89.13M$105.58M
Short-term investments$115.71M$93.59M$57.20M$78.53M$181.48M
Receivables$16.20M$8.14M$17.73M$16.64M$18.47M
Current assets$267.95M$203.01M$146.74M$199.70M$318.23M
PP&E, net$44.81M$48.27M$57.37M$61.94M$19.65M
Total assets$334.16M$270.27M$225.10M$292.70M$396.53M
Current liabilities$39.63M$31.13M$47.23M$33.13M$31.31M
Total liabilities$72.98M$67.31M$95.66M$74.56M$86.23M
Shareholders' equity$261.19M$202.96M$129.44M$218.14M$310.30M
Shares outstanding102.48M85.17M50.48M46.71M44.90M
Cash flow statement
Operating cash flow-$74.95M-$45.15M-$56.26M-$70.23M-$70.83M
Capital expenditure$4.50M$1.60M$10.91M$49.90M$11.08M
Free cash flow-$79.45M-$46.75M-$67.17M-$120.13M-$81.91M
Investing cash flow-$22.57M-$35.07M$13.10M$52.54M-$60.07M
Financing cash flow$130.34M$114.67M$11.03M$1.37M$169.70M
Depreciation & amortization$10.05M$10.94M$11.30M$8.43M$6.01M
Stock-based compensation$9.43M$10.69M$14.05M$19.43M$14.38M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.